High-grade glioma: can we teach an old dogma new tricks?
- PMID: 16530697
- DOI: 10.1016/j.ccr.2006.02.024
High-grade glioma: can we teach an old dogma new tricks?
Abstract
The best efforts of clinicians and biologists battling high-grade glioma (HGG) have been overshadowed by two cruel facts: these tumors are essentially incurable and will kill most patients within months, and emergent knowledge of the genetic alterations in HGG has done nothing to ease this burden of suffering. In this issue of Cancer Cell, Phillips et al. report an extensive study of the gene expression profiles of a large cohort of HGG. Their data provide new clues to the origins of this disease and suggest potential targets for novel therapies.
Comment on
-
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.Cancer Cell. 2006 Mar;9(3):157-73. doi: 10.1016/j.ccr.2006.02.019. Cancer Cell. 2006. PMID: 16530701
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
